Etoposide is a widely used anticancer drug successfully utilized for treatment of many types of cancer in children and adults. Its use, however, is associated with an increased risk of development of secondary acute myelogenous leukemia (t-AML) involving MLL gene (11q23) translocations. Previous studies demonstrated that the phenoxyl radical of etoposide can be produced by action of myeloperoxidase (MPO), an enzyme found in developing myeloid progenitor cells, the likely origin for myeloid leukemias. We hypothesized, therefore, that oneelectron oxidation of etoposide by myeloperoxidase (MPO) to its phenoxyl radical is important for converting this anticancer drug to genotoxic and carcinogenic species in human CD34+ myeloid progenitor cells. In the present study, using EPR spectroscopy, we provide conclusive evidence for MPO-dependent formation of etoposide phenoxyl radicals in growth factor mobilized CD34+ cells isolated from human umbilical cord blood and demonstrate that MPOinduced oxidation of etoposide is amplified in the presence of phenol. Formation of etoposide radicals resulted in oxidation of endogenous thiols thus providing evidence for etoposidemediated MPO-catalyzed redox cycling that may play a role in enhanced etoposide genotoxicity.
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Introduction pyranoside) is a DNA topoisomerase II-targeting agent that has been utilized extensively as an anticancer agent to treat a variety of malignancies in adults and in children (Hande, 1998) .
However, the use of etoposide has been associated with an increased risk of developing secondary leukemias especially acute myelogenous leukemia (t-AML) bearing translocations of the MLL gene at human chromosomal band 11q23 Libura et al., 2005) .
Etoposide, which contains a hindered ring phenol, can be converted to phenoxyl radical forms by the action of peroxidases (Haim et al., 1987; Kagan et al., 1999) . Since myeloid progenitor CD34+ cells in early stages of maturation contain the enzyme myeloperoxidase (MPO) (Strobl et al., 1993) , we hypothesized that oxidative activation of the etoposide phenolic group by MPO may lead to MPO-catalyzed oxidative stress, including carcinogenic oxidative modification of DNA (Kagan et al., 2001) . Hence, MPO expressed in CD34+ cells may make these myeloid progenitors especially sensitive to the leukemogenic action of etoposide.
MPO induced oxidative stress is triggered by this enzyme's reactive intermediates which have very high (1.35V) oxidizing potential (Davies et al., 2008; Jantschko et al., 2005) . In the presence of reducing substrates, particularly phenolic compounds like etoposide, the one-electron oxidation catalyzed by MPO to yield phenoxyl radicals can in turn lead to interaction with a variety of cellular targets including lipids, thiols, ascorbate, proteins, and DNA (Borisenko et al., 2004; Zhang et al., 2002) . Depending on the reactivity of the MPO-generated phenoxyl radicals, the oxidation of these cellular constituents may be directly or indirectly involved in MPO-driven oxidations and/or carcinogenesis (Goldman et al., 1999; Kagan et al., 1999) . Essentially, the reactivity of phenoxyl radicals determines, to a large extent, their overall cytotoxicity and genotoxicity in MPO-expressing CD34+ cells, the likely precursors from which t-AML arises.
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Hence, characterizing the interactions of etoposide phenoxyl radicals with major cellular components is essential for a better understanding of this drug's effects on cells (Kagan et al., 2001 ; Kagan et al., 1999) .
The most direct way to detect and monitor the free radical MPO-initiated reaction is via EPR spectroscopy. Previously, we reported that EPR detection of a phenoxyl radical of etoposide is feasible in MPO-rich human myeloid leukemia HL60 cells (Kagan et al., 2001) . EPR detection of the radicals became possible after depletion of GSH and other thiols suggesting that etoposide radicals (etoposide-O • ) displayed reactivity towards these abundant intracellular reductants . Further, possible involvement of secondary reactions of thiyl radicals leading to the production of superoxide radicals and other reactive oxygen species were considered as important cytotoxic and genotoxic events (Kagan et al., 2001; Kagan et al., 1999) .
To further evaluate whether MPO is a cellular determinant of etoposide oxidation, genotoxicity, and leukomogenesis, we evaluated MPO catalyzed production of etoposide phenoxyl radicals in growth factor mobilized human CD34+ cells, a proximal progenitor model for t-AML. We report for the first time the detection of the EPR signal of etoposide phenoxyl radicals in intact CD34+ cells and demonstrate that this process is MPO-dependent and leads to the depletion of intracellular thiols. In addition, our results demonstrate an MPO-dependent component of etoposide-induced DNA damage and MLL gene rearrangements providing "proof-of-principle" evidence for MPO as a determinant of etoposide leukemogenesis.
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Human myeloid HL-60 cells (from the American Type Culture Collection) were grown continuously in RPMI 1640 medium supplemented with 15% FBS and 2 mM L-glutamine.
CD34+ and HL-60 cells were collected for experiments in mid-log phase growth, 5-8 X 10 5 cell/ml.
MPO Peroxidase Activity in Cell
Homogenates. CD34+ cells were harvested by centrifugation at 500 x g for 5 min. Pellets were washed twice with Buffer A containing 25 mM HEPES and 5 mM NaH 2 PO 4 , pH 7.4, 10 mM glucose, 115 mM NaCl, 5 mM KCl and 1 mM MgCl 2 . Cell homogenates were prepared by freezing at -80°C and then thawing cells.
Measurements of MPO activity were made at room temperature using guaiacol as substrate.
Guaiacol oxidation was monitored by changes of absorbance at 470 nm (ε = 26.6 mM -1 *cm -1 ) using a spectrophotometer (Shimadzu UV 160U, Kyoto, Japan). Cell homogenates (0.1-0.4 x 10 6 cells) were added to 50 mM disodium phosphate buffer containing 0.1% Triton X-100, 0.1 mM PMSF, 10 mM guaiacol, 0.02% cetylmethylammonium bromide, and 3.75 mM 3-AT (pH 7.0).
The reaction was started by the addition of 500 µM H 2 O 2 . Activity of MPO was calculated as nmol tetraguaiacol formed/min/10 6 cells.
In Vitro MPO Peroxidase Activity Using Guaiacol and Etoposide as Substrates.
Peroxidase activity of purified myeloperoxidase was assayed both with guaiacol and etoposide in 50 mM Na-phosphate buffer, pH 7.4, 100 µM DTPA at 25°C. (Kalyanaraman et al. 1989 ).
Flow Cytometry Assay for Intracellular Thiols in Native Cells. After treatment the cells were collected and resuspended in PBS at a density of 0.1 × 10 6 cells/ml followed by incubation with ThioGlo™-1 (10 µM) at room temperature for 10 min after washing once with PBS. The fluorescence of ThioGlo-1 inside cells was measured using a FACscan (BectonDickinson, Rutherford, NJ) flow cytometer, equipped with a 488-nm argon ion laser and supplied with the Cell Quest software. Mean fluorescence intensity from 10,000 cells were acquired using a 530-nm filter (FL-1 channel). Although excitation of ThioGlo-1 at 488-nm is at the tailing end of the absorption spectrum, absorbance was sufficient for recording of emission spectra.
Fluorescence Assay for Low Molecular Weight Thiols (GSH). Low molecular weight thiols (predominantly GSH) in cells were determined using ThioGlo™-1, which produces a This article has not been copyedited and formatted. The final version may differ from this version. highly fluorescent adduct upon its reaction with SH-groups. Cells(0.2 x 10 5 ) were suspended in PBS and lysed by repeated freeze-thaw. GSH content was estimated by an immediate fluorescence response registered upon addition of ThioGlo-1 to the cell homogenate using excitation at 388 nm and emission at 500 nm. The total amount of protein was determined using the Bradford assay.
Cytogenetic Analysis for MLL Gene Rearrangements. Growth factor-mobilized CD34+ cells were treated for 60 min with etoposide (50 µM) or with vehicle (DMSO). Cells were then washed free of drug and allowed to grow for an additional 7 days after which they were treated with Colcemid TM (0.1 mg/mL) for one hr before standard cytogenetic harvesting.
After mitotic arrest, the cells were incubated in 0.075 M KCl, fixed with Carnoy's fixative ( pellets. Gentle resuspension in 1.5 ml ice-cold 1 X PBS (calcium-and magnesium-free) was followed by a second centrifugation and resuspension of pellets in 0.5 ml of the same ice cold PBS. Thirty µl of cell suspension was carefully mixed with 300 µl of low melting temperature agarose (Trevigen LMagarose) at 39 0 C. A cell/agarose mixture (75 µl) was then transferred evenly to Trevigen COMET glass slides which were immediately placed in a dessicator jar at 4 0 C in the dark for 30 min to allow the agarose to set. Slides were then transferred into pre-chilled Trevigen lysis solution for 2 hr in the dark. Next, the slides were immersed in an alkaline solution (pH>13, 300 mM NaOH, 1mM EDTA) for 1 hr in the dark at room temperature. Slides were transferred to the center of a horizontal gel electrophoresis apparatus (with electrodes 34 cm apart) containing just enough ice-cold alkaline solution (pH>13, 300 mM NaOH) to cover the slides. Electrophoresis proceeded in a cold room at 1 V/cm for 45 min. After electrophoresis, the slides were drained of excess alkaline solution, immersed in 70% ethanol for 5 min and air dried overnight. Slides were stained with SYBR green and images were visualized under a This article has not been copyedited and formatted. The final version may differ from this version. 12 fluorescence microscope and captured with a CCD camera. Images were imported and analyzed utilizing a version of CASP, the public domain program specifically designed for the Comet assay (Konca et al., 2003) . From each slide at least 150 cells were analyzed. DNA damage is presented as the Olive tail moment in etoposide-treated minus DMSO-treated cells. The Olive tail moment is defined as the product of the comet tail length and the fraction of total DNA in the comet tail (Olive, 2002 (Kagan et al., 2001) . In those studies etoposide-O (Kalyanaraman et al. 1989) . Growth factor mobilization of the CD34+ progenitors leads to a progressive expression of MPO (Morabito et al., 2005) . MPO activity in these CD34+ cells cultured for one week in the presence of 100 µg/ml SCF, IL-3, and G-CSF was found to be 9.0 ± 2.5 nmol tetraguaiacol formed/min/10 6 cells. In contrast, freshly isolated CD34+ cells contained no detectable MPO activity and did not convert etoposide to its phenoxyl radical (Fig. 1A,a) . (Fig. 1A,d ).
We next demonstrated that the formation of etoposide-O
• radicals in CD34+ cells is a heme-mediated process. To this end we used succinylacetone (SA), an inhibitor of heme synthesis (Pinnix et al., 1997) , and studied its effect on the EPR signal of etoposide-O Cyanide (0.5 mM), an inhibitor of heme-containing enzymes, inhibited etoposide-O
• formation by about 90% (Fig. 1A,f) . Although cyanide and SA are not highly specific inhibitors of MPO but rather block heme-containing enzymes and total heme synthesis, respectively, together these results strongly suggest that H 2 O 2 -dependent MPO catalysis is involved in the generation of etoposide-O
• radicals, especially since MPO is a major heme-containing protein in growth factor mobilized CD34+ cells and there is little expression of cytochromes P450 in CD34+ cells capable of etoposide oxidation (Soucek et al., 2005) . oxidation of reducing substrates such as phenolic compounds to form phenoxyl radicals (Davies et al., 2008; Jantschko et al., 2005) . In spite of its low redox potential (E 0 = 0.56 V), etoposide is expected to be a very poor substrate for MPO because access of this large phenolic compound (MW=589) to the MPO active site is highly constrained. The MPO active site is located at the base of a narrow and deep heme pocket (Day et al., 1999; Zhang et al., 2002) . We measured MPO activity using both etoposide and guaiacol as substrates. MPO activity towards etoposide was 2 orders of magnitude less than that towards guaiacol (k cat = 8.8 ± 2.4/min versus 1050 ± 150/min, respectively). This result is consistent with our observation that high concentrations of etoposide are required to observe MPO-catalyzed production of etoposide-O
Effect of Phenol on MPO-dependent
• .
Compared to etoposide, small phenolic molecules (phenol, tyrosine) are good substrates of MPO (Goldman et al., 1999) . These small molecules may act as co-substrates for oxidation of large, bulky compounds like etoposide because they have free access to the MPO active site and because of the relatively high oxidizing potential (about 0.7-0. Fig.2A,a) . Under the same experimental conditions but in the presence of 100 µM phenol, the production of etoposide-O
• after 1 min increased dramatically ( Fig. 2A,b) .
The concentration dependent effects of phenol on purified MPO enzyme oxidation of etoposide are demonstrated in Fig. 2B , upper curve. If cellular etoposide oxidation is similarly catalyzed by MPO, then phenol-induced enhancement of etoposide oxidation should be observed in intact CD34+ cells. Indeed, we next demonstrate the phenol dependent amplification of the EPR signal of etoposide phenoxyl radicals in MPO-rich human leukemia HL-60 cells and in growth factor mobilized CD34+ cells (Fig. 2B) . In cells there are many potential intracellular targets beside etoposide and thiols for the highly reactive phenol radicals. For example, in contrast to etoposide phenoxyl radicals, phenol-derived phenoxyl radicals react with lipids and proteins and oxidize them very well (Goldman et al., 1999; Tyurina et al., 2006) . This may This article has not been copyedited and formatted. The final version may differ from this version. by comparison, reliable increases of the etoposide radical signal (30%) were observed at much higher added phenol concentrations (50 µM) and only after depletion of intracellular thiols (using ThioGlo-1), one of the main targets of phenoxyl radicals (Fig. 2B) . Conversely, it is also possible that the increase of etoposide radical signals under these conditions may be mediated via secondary phenoxyl radical reactions such as oxidation of tyrosines, tryptophans, and lipids resulting in intermediates with high oxidizing redox potentials. Overall, in cells, the phenol dependent enhancement of etoposide-O
• production indicates that MPO is involved in etoposide oxidation.
Effects of Etoposide on H 2 O 2 -Induced Oxidation of Endogenous Thiols in Human CD34+ Cells. Our previous studies demonstrated that etoposide-O
• radicals are reactive toward:
1) intracellular reductants such as ascorbate Kagan et al., 1994 ) (suggesting a future chemoprevention strategy to diminish the leukemogenic effects of etoposide) and 2) endogenous thiols such as GSH (Kagan et al., 2001; Kagan et al., 1999; Tyurina et al., 1995 was several times greater after ThioGlo-1 treatment (Fig. 3A) . When cells were pretreated with Thioglo-1, the magnitude of the signal increased over time and then declined ( Fig. 3B) likely due to depletion of H 2 O 2 . In the absence of ThioGlo-1 there was a less pronounced increase in the EPR signal and a more dramatic decline of the signal within 10 min of addition of This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 4B) . At various time points, aliquots of CD34+ cell suspension were taken for measurements of low molecular weight thiol content by flow cytometry after addition of ThioGlo-1. In addition, for estimation of low molecular weight thiol content in CD34+ cells, the immediate fluorescence response to the addition of ThioGlo-1 in cell homogenates was measured in a spectrofluorimeter. Protein SH-groups were determined by the additional increase in fluorescence response after the addition of SDS (4 mM) to the same cell homogenates. The validity of this technique for assessment of low molecular weight thiols and protein-SH groups has previously been demonstrated (Kagan et al., 2001 ).
We observed a time dependent decrease in low molecular weight thiol content both in intact cells by flow cytometry (Fig. 4B,a) and in cell homogenates by spectrofluorimetry (Fig.   4B,b) . In contrast there was no statistically significant decrease in free total protein SH content after 45 min incubation with etoposide and H 2 O 2 (Fig. 4B,c) .
These results are consistent with the idea that the abundant low molecular weight thiols such as GSH are the immediate reductants of the etoposide-O (Fig 1A,e) but also in a reduction in both etoposideinduced DNA damage (Fig. 5) and MLLR.
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Discussion
This report presents, for the first time, direct detection and monitoring of etoposide radicals and their enhancement by small phenolic molecules in CD34+ myeloid progenitor cells.
Detection of free radicals in cells is not trivial. Few reports have been published demonstrating endogenous production of free radicals in cells or in animals. An ESR spin-trapping system was successfully implemented to detect free radicals produced in rodents after treatment with tertbutyl hydroperoxide (Hix et al., 2000) . A spin trapping technique was utilized as well for Detection of etoposide phenoxyl radicals in bone marrow CD34+ progenitor cells, the likely precursors from which myeloid tumors arise, is critical to understand the genotoxic effects of etoposide. These myeloid progenitor cells contain MPO even in the early stages of maturation (Strobl et al., 1993) . In our experiments, after addition of etoposide to human CD34+ cells, we were able to detect and monitor the EPR signal of etoposide phenoxyl radicals. Detection of etoposide phenoxyl radicals was dependent on depletion of non-protein thiols such as GSH by preincubation of cells with the maleimide reagent ThioGlo-1. At the same time we were able to obtain EPR spectra with distinguishable EPR signals even without ThioGlo-1. The radical signal can be measured reliably after repeated additions of H 2 O 2 and (etoposide+H 2 O 2 ) indicating that intracellular reactions of etoposide radicals lead to depletion of endogenous GSH (Fig. 3, Fig.   4A ). Because the sensitivity of EPR spectroscopy is relatively low, we employed higher concentrations of etoposide. Nevertheless these concentrations were clinically relevant since etoposide plasma levels of 100 µg/ml (180 µM) can be achieved in patients receiving high doses of etoposide phenoxyl radicals was demonstrated to be a heme-mediated process since phenoxyl radical formation was inhibited by addition of cyanide or by pre-incubation of cells with the heme-synthesis inhibitor, succinylacetone. Finally, the established MPO substrate, phenol, amplified production of etoposide phenoxyl radicals within cells strongly suggesting that MPOcatalyzed one-electron oxidation is responsible for etoposide "activation".
As a bulky molecule etoposide is a relatively poor substrate for MPO compared to the small molecule phenol which has greater access to the relatively restricted active site of the enzyme (Day et al., 1999; Zhang et al., 2002) . MPO dependent production of non-specific phenol radicals results in subsequent production of the etoposide-O
• based on its specific property as a phenoxyl radical with low redox potential compared to phenol-derived phenoxyl radicals (Goldman et al., 1997; Goldman et al., 1999) . Hence, incubation of MPO-rich cells with both phenol and etoposide may be responsible for converting non-specific phenol radicals, which are broadly reactive towards different biomolecules, to specific interactions of etoposide-O
• radicals with GSH and protein-SH groups. This specificity may be responsible for modified and/or inhibited protein activities.
Since the etoposide phenoxyl radical is relatively long-lived compared to the phenol radical (Goldman et al. 1997; Tyurina et al., 2006) , the oxidative potential of MPO can be more readily transferred to the nucleus when cells are relatively depleted of intracellular reductants. In
This article has not been copyedited and formatted. The final version may differ from this version. addition, it has been demonstrated that MPO can be found in the nucleus of normal and leukemic human myeloid cells (Murao et al., 1988) . Hence, one suggestion from our results is that exposure of MPO-containing myeloid progenitors to etoposide or concurrently to etoposide and phenols increases the risk of etoposide-induced secondary acute myeloid leukemias based on increased oxidative stress and potential oxidative DNA damage resulting in abasic DNA sites.
These abasic sites can act to enhance DNA topoisomerase II poisoning (Kingma et al., 1997) and may thereby increase the recombinogenic activity of etoposide.
In support of the idea that hematopoietic cell cytotoxicity (and presumably genotoxicity)
can be enhanced by MPO catalyzed oxidation of phenol, it was reported that phenol stimulated hydroquinone oxidation by peroxidases (Smith et al., 1989) . In addition, repeated coadministration of phenol and hydroquinone to B6C3F 1 mice resulted in a dramatic decrease in bone marrow cellularity (Eastmond et al., 1987) . Together with results presented here, these reports raise a cautionary note concerning environmental phenol exposure in patients receiving etoposide therapy. In contrast, dietary flavonoids, relatively weak oxidants, can be viewed as potentially important competitive inhibitors of MPO-catalyzed etoposide oxidation useful for the prevention of etoposide genotoxicity.
Peroxidase-dependent formation of phenoxyl radicals in the presence of glutathione is known to derive thiyl radicals and to provide an additional important source of reactive oxygen species thus propagating oxidative stress in MPO-rich cells (Borisenko et al., 2004) . . Acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion (Libura et al., 2005) . Etoposide promotes specific rearrangements of MLL in CD34+ consistent with the full spectrum of oncogenic events identified in leukemic samples. (Hutt and Kalf, 1996) . Regardless of the mechanism(s) responsible for etoposide-induced leukemogenesis, our results demonstrate MPO-dependency for both etoposide-induced DNA damage (Fig. 5) tyrosinase may contribute to its cytotoxicity (Haim et al., 1987; Relling et al., 1994; Usui and Sinha, 1990) . However, these enzymes are not expressed appreciably in CD34+ cells (Fan et al., 2006) . We hypothesize, therefore, that it is the oxidizing enzyme MPO in highly proliferative CD34+ cells that increases the risk of etoposide-induced secondary leukemias.
Oxidation of etoposide results in formation of several metabolites (Fan et al., 2006; Zheng et al., 2006) . Patients receiving etoposide accumulate appreciable levels of etoposide catechol catalyzed by the action of CYP3A4 and CYP3A5 Zhuo et al., 2004) . Etoposide catechol can be converted to semiquinone radicals by one electron oxidation catalyzed by MPO. MPO may also catalyze (in cells and in vitro) the formation of a twoelectron oxidation product of etoposide, etoposide ortho-quinone that forms conjugates with GSH (Fan et al., 2006; Mans et al., 1992; Zheng et al., 2006) and may be responsible in part for the cyto-and genotoxic effects of etoposide due to its ability to stabilize topoisomerase II/DNA covalent complexes as studied in vitro (Lovett et al., 2001 ).
In conclusion, our study demonstrates MPO-dependent generation of etoposide-O cells treated with ThioGlo-1 were at a concentration of 3 ± 0.5 X 10 6 cells/ml. All other experimental conditions were the same as detailed in the legend to Fig.1 . 
